• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent Use Codes

This page defines the patent use codes.

Displaying records 1 to 200 of 1560 Download data Download data       Previous Page  |  Next Page
Code Definition
U - 1 PREVENTION OF PREGNANCY
U - 2 TREATMENT OR PROPHYLAXIS OF ANGINA PECTORIS AND ARRHYTHMIA
U - 3 TREATMENT OF HYPERTENSION
U - 4 PROVIDING PREVENTION AND TREATMENT OF EMESIS AND NAUSEA IN MAMMALS
U - 5 METHOD OF PRODUCING BRONCHODILATION
U - 6 METHOD OF PRODUCING SYMPATHOMIMETIC EFFECTS
U - 7 INCREASING CARDIAC CONTRACTILITY
U - 8 ACUTE MYOCARDIAL INFARCTION
U - 9 CONTROL OF EMESIS ASSOCIATED WITH ANY CANCER CHEMOTHERAPY AGENT
U - 10 DIAGNOSTIC METHOD FOR DISTINGUISHING BETWEEN HYPOTHALMIC MALFUNCTIONS OR LESIONS IN HUMANS
U - 11 TREATMENT OR PROPHYLAXIS OF CARDIAC DISORDERS
U - 12 METHOD OF TREATING [A] HUMAN SUFFERING FROM DEPRESSION
U - 13 A METHOD FOR TREATING ANXIETY IN A HUMAN SUBJECT IN NEED OF SUCH TREATMENT
U - 14 ADJUNCTIVE THERAPY FOR THE PREVENTION AND TREATMENT OF HYPERAMMONEMIA IN THE CHRONIC MANAGEMENT OF PATIENTS WITH UREA CYCLE ENZYMOPATHIES
U - 15 METHOD OF LOWERING INTRAOCULAR PRESSURE
U - 16 USE IN LUNG SCANNING PROCEDURES
U - 17 TREATMENT OF VENTRICULAR AND SUPRAVENTRICULAR ARRHYTHMIAS
U - 18 METHOD FOR INHIBITING GASTRIC SECRETION IN MAMMALS
U - 19 TREATMENT OF INFLAMMATION
U - 20 A PROCESS FOR TREATING A PATIENT SUFFERING FROM PARKINSON'S SYNDROME AND IN NEED OF TREATMENT
U - 21 TREATMENT OF HUMANS SUFFERING UNDESIRED UROTOXIC SIDE EFFECTS CAUSED BY CYTOSTATICALLY ACTIVE ALKYLATING AGENTS
U - 22 METHOD OF COMBATTING PATHOLOGICALLY REDUCED CEREBRAL FUNCTIONS AND PERFORMANCE WEAKNESSES, CEREBRAL INSUFFICIENCY AND DISORDERS IN CEREBRAL CIRCULATION AND METABOLISM IN WARM-BLOODED ANIMALS
U - 23 METHOD FOR TREATING PROSTATIC CARCINOMA COMPRISING ADMINISTERING FLUTAMIDE
U - 24 METHOD FOR TREATING PROSTATE ADENOCARCINOMA COMPRISING ADMINISTERING AN ANTIANDROGEN INCLUDING FLUTAMIDE AND AN LHRH AGONIST
U - 25 REDUCING CHOLESTEROL IN CHOLELITHIASIS PATIENTS
U - 26 REDUCING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THEREOF
U - 27 DISSOLVING CHOLESTEROL GALLSTONES AND/OR FRAGMENTS THEREOF
U - 28 CEREBRAL, CORONARY, PERIPHERAL, VISCERAL AND RENAL ARTERIOGRAPHY, AORTOGRAPHY AND LEFT VENTRICULOGRAPHY
U - 29 CT IMAGING OF THE HEAD AND BODY, AND INTRAVENOUS EXCRETORY UROGRAPHY
U - 30 CEREBRAL ANGIOGRAPHY, AND VENOGRAPHY
U - 31 INTRA-ARTERIAL DIGITAL SUBTRACTION ANGIOGRAPHY
U - 32 PALLIATIVE TREATMENT OF PATIENTS WITH OVARIAN CARCINOMA RECURRENT AFTER PRIOR CHEMOTHERAPY, INCLUDING PATIENTS WHO HAVE BEEN PREVIOUSLY TREATED WITH CISPLATIN
U - 33 TREATING VIRAL INFECTIONS IN A MAMMAL
U - 34 TREATING VIRAL INFECTIONS IN A WARM-BLOODED ANIMAL
U - 35 TREATING CYTOMEGALOVIRUS IN A HUMAN WITH AN INJECTABLE COMPOSITION
U - 36 METHODS OF TREATING BACTERIAL ILLNESSES
U - 37 METHOD OF TREATING GASTROINTESTINAL DISEASE
U - 38 TREATMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA
U - 39 ANGINA PECTORIS
U - 40 METHOD OF TREATMENT OF BURNS
U - 41 METHOD OF TREATING CARDIAC ARRHYTHMIAS
U - 42 ADJUVANT TREATMENT IN COMBINATION WITH FLUOROURACIL AFTER SURGICAL RESECTION IN PATIENTS WITH DUKES' STAGE C COLON CANCER
U - 43 MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA
U - 44 RELIEF OF NAUSEA AND VOMITING
U - 45 TREATMENT OF INFLAMMATION AND ANALGESIA
U - 46 TREATMENT OF PANIC DISORDER
U - 47 STIMULATION OF THE RELEASE OF GROWTH HORMONE
U - 48 ANALGESIA
U - 49 SYMPTOMATIC CANCER-RELATED HYPERCALCEMIA
U - 50 USE IN TREATING INFLAMMATORY DERMATOSES
U - 51 BLOOD POOL IMAGING, INCLUDING CARDIAC FIRST PASS AND GATED EQUILIBRIUM IMAGING AND FOR DETECTION OF SITES OF GASTROINTESTINAL BLEEDING
U - 52 TREATMENT OF ADULT AND PEDIATRIC PATIENTS(OVER SIX MONTHS OF AGE) WITH ADVANCED HIV INFECTION
U - 53 HYPERCALCEMIA OF MALIGNANCY
U - 54 REVERSAL AGENT OR ANTAGONIST OF NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS
U - 55 TREATMENT OF PAIN
U - 56 AID TO SMOKING CESSATION
U - 57 OPHTHALMIC USE OF NORFLOXACIN
U - 58 METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES
U - 59 METHOD OF TREATING HYPERCHOLESTEROLEMIA
U - 60 NASAL ADMINISTRATION OF BUTORPHANOL
U - 61 CEREBRAL AND PERIPHERAL ARTERIOGRAPHY AND CT IMAGING OF THE HEAD
U - 62 CORONARY ARTERIOGRAPHY, LEFT VENTRICULOGRAPHY, CT IMAGING OF THE BODY, INTRAVENOUS EXCRETORY UROGRAPHY, INTRAVENOUS DIGITAL SUBTRACTION ANGIOGRAPHY AND VENOGRAPHY
U - 63 ISOPRENALINE ANTAGONISM ON THE HEART RATE OR BLOOD PRESSURE
U - 64 TREATMENT OF VIRAL INFECTIONS
U - 65 METHOD OF TREATMENT OF A PATIENT INFECTED WITH HIV
U - 66 TRIPHASIC REGIMEN
U - 67 METHOD OF INDUCING ANESTHESIA IN A WARM BLOODED ANIMAL
U - 68 TREATMENT OF ACTINIC KERATOSIS
U - 69 TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS
U - 70 TREATMENT OF TRANSIENT INSOMNIA
U - 71 METHOD OF TREATMENT OF HEART FAILURE
U - 72 TREATMENT OF MIGRAINE
U - 73 METHOD OF TREATING DISEASES OR INFECTIONS CAUSED BY MYCETES
U - 74 METHOD OF PROVIDING HYPNOTIC EFFECT
U - 75 RELIEF OF OCULAR ITCHING DUE TO SEASONAL ALLERGIC CONJUNCTIVITIS
U - 76 USE TO IMAGE A SUBJECT WITH A MAGNETIC RESONANCE IMAGING SYSTEM
U - 77 TREATMENT OF SYMPTOMS OF SEASONAL ALLERGIC RHINITIS
U - 78 ULCERATIVE COLITIS
U - 79 SYMPTOMATIC TREATMENT OF PATIENTS WITH NOCTURNAL HEARTBURNDUE TO GERD
U - 80 METHOD OF TREATING OCULAR BACTERIAL INFECTIONS
U - 81 RELIEF OF SYMPTOMS ASSOCIATED WITH SEASONAL ALLERGIC RHINITIS
U - 82 TREATMENT FOR DEMENTIA IN PATIENTS WITH ALZHEIMER'S DISEASE
U - 83 TREATMENT OF SEIZURES
U - 84 A METHOD OF BLOCKING THE UPTAKE OF MONOAMINES BY BRAIN NEURONS IN ANIMALS
U - 85 NASAL TREATMENT OF SEASONAL AND PERENNIAL ALLERGIC RHINITIS SYMPTOMS
U - 86 METHOD OF TREATING CERTAIN FORMS OF EPILEPSY
U - 87 METHOD FOR NONINVASIVE ADMINISTRATION OF SEDATIVES, ANALGESICS, AND ANESTHETICS
U - 88 TREATMENT OF MODERATE PLAQUE PSORIASIS
U - 89 TREATMENT OR PROPHYLAXIS OF EMESIS
U - 90 TREATMENT OF PYSCHOTIC DISORDERS
U - 91 ALTERNATIVE THERAPY TO TRIMETHOPRIM-SULFAMETHOXAZOLE FOR TREATMENT OF MODERATE-TO-SEVERE PNEUMOCYSTIS CARINII PNEUMONIA IN IMMUNOCOMPROMISED AND AIDS PATIENTS
U - 92 TREATMENT OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE I INSULIN DEPENDENT DIABETES MELLITUS AND RETINOPATY
U - 93 USE AS AN ANTIHISTAMINE/DECONGESTANT
U - 94 TREATMENT-ADULTS W/ ADVANCED HIV,INTOLERANT OF APPROVED THERAPIES,INTOLERANT OF APPROVED THERAPIES W/PROVEN BENEFIT OR HAVE EXPERIENCED CLINICAL/IMMUNOLOGICAL DETERIORATION WHILE RECEIVING..OR FOR WHOM SUCH THERAPIES-CONTRAINDICATED
U - 95 SHORT TERM MANAGEMENT OF MODERATE PRURITIS IN ADULTS WITH ATOPIC DERMATITIS AND LICHEN SIMPLEX CHRONICUS
U - 96 METHOD OF TREATING VARICELLA ZOSTER (SHINGLES) INFECTIONS
U - 97 A METHOD OF TREATING A PATIENT IN NEED OF MEMORY ENHANCEMENT
U - 98 A METHOD OF INDUCING REGRESSION OF LEUKEMIA CELL GROWTH IN A MAMMAL
U - 99 METHOD OF PROVIDING POTASSIUM TO A SUBJECT IN NEED OF POTASSIUM
U - 100 METHOD OF TREATING OCULAR INFLAMMATION
U - 101 ADJUNCT TO CONVENTIONAL CT OR MRI IMAGING IN THE LOCALIZATION OF STROKE IN PATIENTS IN WHOM STROKE HAS ALREADY BEEN DIAGNOSED
U - 102 METHOD OF HORMONALLY TREATING MENOPAUSAL OR POST-MENOPAUSAL DISORDERS IN WOMEN
U - 103 TREATMENT OF OCULAR HYPERTENSION
U - 104 TREATMENT OF AQUEOUS HUMOR FORMATION AND INTRAOCULAR PRESSURE
U - 105 EMESIS
U - 106 TREATMENT OF EPILEPSY
U - 107 TREATMENT OF HYPERTENSION AND ANGINA PECTORIS
U - 108 SHORT-TERM TREATMENT OF ACTIVE DUODENAL ULCER, GASTROESOPHAGEAL REFLUX DISEASE (GERD), SEVERE EROSIVE ESOPHAGITIS, POORLY RESPONSIVE SYMPTOMATIC GERD AND PATHOLOGIAL HYPERSECRETORY CONDITIONS AND MAINTENANCE HEALING OF EROSIVE ESOPHAGITIS
U - 109 ADJUNCT DIET IN THE TX OF ELEVATED TOTAL CHOLESTEROL AND LDL-C LEVELS IN PTS W/PRIMARY HYPERCHOLESTEROLEMIA WHOSE RESPONSE TO DIETARY RESTRICTION OF SAT FAT AND CHOLESTEROL AND OTHER NONPHARMACOLOGICAL MEASURES HAS NOT BEEN ADEQUATE
U - 110 USE AS A RETRIEVABLE PERSSARY
U - 111 DIABETES
U - 112 CONTRACEPTION
U - 113 METHOD OF CONDUCTING RADIOLOGICAL EXAMINATION OF A PATIENT BY ADMINISTERING TO SAID PATIENT A RADIOPAQUE AMOUNT OF IOPROMIDE
U - 114 USE FOR INHIBITING BONE RESORPTION
U - 115 USE OF VASODILATORS TO EFFECT AND ENHANCE AN ERECTION (AND THUS TREAT ERECTILE DYSFUNCTION), BY INJECTION INTO THE PENIS
U - 116 METHOD OF MYOCARDIAL IMAGING
U - 117 TREATMENT OF OCULAR ALLERGIC RESPONSE IN HUMAN EYES
U - 118 METHOD OF LOWERING BLOOD SUGAR LEVEL
U - 119 TREATMENT OF NASAL HYPERSECRETION
U - 120 CONTROLLING OR PREVENTING POST-OPERATIVE INTRAOCULAR PRESSURE RISES ASSOCIATED WITH OPHTHALMIC LASER SURGICAL PROCEDURES
U - 121 METHOD OF TREATING CONDITIONS MEDIATED THROUGH HISTAMINE H2-RECEPTORS
U - 122 A THERAPEUTIC METHOD FOR CONTROLLING THROMBOSIS
U - 123 METHOD FOR CONTROLLING THROMBOSIS AND DECREASING BLOOD HYPERCOAGULATION AND HEMORRHAGING RISKS
U - 124 TREATMENT OF ACNE
U - 125 TREATMENT NEUROGENERATIVE DISEASES
U - 126 TREATMENT OF GASTRITIS
U - 127 METHOD OF PRODUCING NEUROMUSCULAR BLOCKADE
U - 128 METHOD FOR TREATMENT OF TUMORS
U - 129 METHOD TO DESTROY OR IMPAIR TARGET CELLS
U - 130 MANAGEMENT OF PATIENTS WITH MASTOCYTOSIS
U - 131 PHOTODAMAGED SKIN
U - 132 INHIBITING HIV PROTEASE
U - 133 MANAGEMENT OF OBESITY INCLUDING WEIGHT LOSS AND MAINTENANCE IN PATIENTS ON A REDUCED-CALORIE DIET
U - 134 TREATMENT OF ACNE VULGARIS
U - 135 ANTITUMOR AGENT
U - 136 PROCESS FOR WASTE NITROGEN REMOVAL
U - 137 METHOD OF TREATING BACTERIAL VAGINOSIS
U - 138 TREATMENT OF ALLERGIC RHINITIS
U - 139 TREATMENT OF ALLERGIC REACTIONS
U - 140 USE OF NORVIR TO INHIBIT HIV PROTEASE OR TO INHIBIT AN HIV INFECTION
U - 141 TREATMENT OF ULCERATIVE COLITIS
U - 142 METHOD OF TREATING ALLERGIC REACTIONS IN A MAMMAL BY USING THIS ACTIVE METABOLITE
U - 143 BIODEGRADABLE SUPERPARAMAGNETIC METAL OXIDES AS CONTRAST AGENTS FOR MR IMAGING
U - 144 BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC MATERIALS FOR USE IN CLINICAL APPLICATIONS
U - 145 BIOLOGICALLY DEGRADABLE SUPERPARAMAGNETIC PARTICLES FOR USE AS NUCLEAR MAGNETIC RESONANCE IMAGING AGENTS
U - 146 METHOD OF TREATING SUSCEPTIBLE NEOPLASMS IN MAMMALS
U - 147 DETECTION OF GASTROINTESTINAL DISORDERS AND THE SUBSEQUENT BREATH COLLECTION AND MEASUREMENT OF 13CO2
U - 148 DEVICE FOR COLLECTING A BREATH SAMPLE
U - 149 METHOD OF TREATING AN ANIMAL, INCLUDING A HUMAN SUFFERING FROM OR SUSCEPTIBLE TO PSYCHOSIS, ACUTE MANIA OR MILD ANXIETY STATES
U - 150 METHOD OF USE FOR CONTROLLING HYPERGLYCEMIA BY ADMINISTRATION OF THIS SUSTAINED RELEASE DOSAGE FORM OF GLIPIZIDE
U - 151 RELIEF OF SYMPTOMS OF THE COMMON COLD
U - 152 METHOD OF TREATING ANXIETY RELATED DISORDERS INCLUDING OBSESSIVE COMPULSIVE DISORDER
U - 153 TREATMENT OF INITIAL EPISODE GENITAL HERPES
U - 154 METHOD OF TREATING ANIMALS SUFFERING FROM AN APPETITE DISORDER
U - 155 TREATMENT OF ERECTILE DYSFUNCTION
U - 156 METHOD OF PROVIDING ANESTHESIA
U - 157 TREATMENT OF A HUMAN SUFFERING FROM VITAMIN B12 DEFICIENCY
U - 158 ANGINA
U - 159 TREATMENT OF INTERSTITIAL CYSTITIS
U - 160 TREATMENT OF BACTERIAL INFECTIOUS DISEASE
U - 161 METHOD OF INHIBITING CHOLESTEROL BIOSYNTHESIS IN A PATIENT
U - 162 METHOD OF USE TO INHIBIT CHOLESTEROL SYNTHESIS IN A HUMAN SUFFERING FROM HYPERCHOLESTEROLEMIA
U - 163 METHOD OF USING TROGLITAZONE TO TREAT IMPAIRED GLUCOSE TOLERANCE TO PREVENT OR DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUS
U - 164 METHOD OF USING TROGLITAZONE TO PREVENT OR DELAY THE ONSET OF NONINSULIN-DEPENDENT DIABETES MELLITUS IN A DEFINED POPULATION OF PATIENTS
U - 165 TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
U - 166 TREATMENT OF H.PYLORI-ASSOCIATED DUODENAL ULCER
U - 167 METHOD FOR TREATING HIV-1 INFECTION
U - 168 METHOD OF INHIBITING LIPOXYGENASE ACTIVITY IN A MAMMAL WHICH IS THE MODE OF ACTION IN THE TREATMENT OF ASTHMA
U - 169 METHODS OF USING THE COMPOUND/DRUG PRODUCT AS A CONTRAST AGENT IN MAGNETIC RESONANCE IMAGING
U - 170 METHOD OF OBTAINING AN MR IMAGE USING THE COMPOSITION/DRUG PRODUCT AS A CONTRAST AGENT
U - 171 METHODS OF USING THE COMPOUND/DRUG PRODUCT AS AN ORAL CONTRAST AGENT IN MAGNETIC RESONANCE IMAGING OF THE GASTROINTESTINAL TRACT
U - 172 TREATMENT OF GENITAL WARTS
U - 173 ADMINISTRATION TO A HOST SUFFERING FROM GESTATIONAL DIABETES
U - 174 USE AS AN ANTIHISTAMINE AGENT
U - 175 METHOD OF TREATING MALIGNANT TUMORS
U - 176 METHOD OF TREATING A PATIENT SUFFERING FROM LISTED CONDITIONS, INCLUDING SPECIFIC PSYCHOSES
U - 177 FUNGICIDE
U - 178 FACILITATED ADHERENCE OF AGENTS TO SKIN
U - 179 ENHANCED CUTANEOUS PENETRATION OF A DERMALLY-APPLIED PHARMACOLOGICALLY ACTIVE AGENT
U - 180 TREATMENT OF ADULT AND PEDIATRIC PATIENTS (OVER 6 MONTHS OF AGE) WITH ADVANCED HIV INFECTION
U - 181 PRODUCING ALPHA ADRENERGIC ANTAGONISTIC ACTION IN A HOST
U - 182 USE OF SALMETEROL IN PATIENTS WITH REVERSIBLE AIRWAY OBSTRUCTION
U - 183 TREATMENT OF CONDITIONS CAUSED BY DISTURBANCE OF NEURONAL 5HT FUNCTION
U - 184 TREATING ALLERGIC EYE DISEASES IN HUMANS
U - 185 METHOD OF TREATING HYPERTENSION
U - 186 METHOD FOR TREATING GI DISORDERS CAUSED BY H.RYLORI WHICH COMPRISES ADMINISTRATION OF RANITIDINE BISMUTH CITRATE AND CLARITHROMYCIN FOR A GREATER THAN ADDITIVE EFFECT
U - 187 THERAPEUTIC TREATMENT OF CALCIFIC TUMORS
U - 188 TREATMENT OF H.PYLORI ASSOCIATED DUODENAL ULCER
U - 189 ENHANCEMENT OF THE BIOAVAILABILITY OF THE DRUG SUBSTANCE
U - 190 USE OF RITONAVIR IN COMBINATION WITH ANY REVERSE TRANSCRIPTASE INHIBITOR
U - 191 METHOD OF TREATMENT FOR CONTROLLING AND LOWERING INTRAOCULAR PRESSURE IN A HUMAN
U - 192 USE IN TREATING ALLERGIC REACTIONS
U - 193 PSORIASIS
U - 194 TREATING ANGINA PECTORIS AND HIGH BLOOD PRESSURE
U - 195 METHOD FOR THE DIAGNOSIS OF GASTROINTESTINAL DISORDERS BY UREA ISOTOAC OR NITROGEN LABELED CARBON
U - 196 TREATMENT OF METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR POSITIVE TUMORS
U - 197 USE IN COMBINATION WITH CERTAIN LHRH ANALOGUES FOR THE TREATMENT OF ADVANCED PROSTATE CANCER
U - 198 TREATMENT METASTATIC CARCINOMA OF OVARY AFTER 1ST LINE FAILURE OR SUBSQUENT CHEMOTHERAPY, TREATMENT OF BREAST CANCER AFTER FAILURE OF COMBINATION CHEMOTHERAPY FOR METASTATIC DISEASE AND 2ND LINE TREATMENT OF AIDS RELATED KAPOSI'S SARCOMA
U - 199 METHOD OF TREATING INFECTIOUS UPPER GI TRACT DISORDERS CAUSED BY CAMPYLOBACTER PYLORIDIS INFECTION COMPRISING ADMINISTRATION OF A BISMUTH AGENT AND AN ANTIMICROBIAL AGENT
U - 200 METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF A BISMUTH-CONTAINING AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENT

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through July 2014
Patent and Generic Drug Product Data Last Updated August 29, 2014

-
-